Skip to main content

Table 2 Results of estimated Laboratory parameters in blood samples obtained at the time of admission of studied AF patients categorized according to the outcome of CA

From: Pre-procedural high serum visfatin and tumor necrosis factor-α might predict recurrent atrial fibrillation after catheter ablation

Parameters

RAF (n = 41)

No RAF (n = 76)

Significance of difference (p)

Fasting blood glucose (mg/dl)

118.1 ± 13.3

117.4 ± 13.7

0.786

2-postprandial blood glucose (mg/dl)

173.6 ± 32.7

170.6 ± 35.5

0.651

Blood glycosylated hemoglobin A1c (%)

6.15 ± 0.63

6.3 ± 0.59

0.219

Total blood cholesterol (mg/dl)

235.5 ± 31

225.9 ± 31.5

0.116

Triglyceride (mg/dl)

173.2 ± 29.1

164.2 ± 27.3

0.079

High-sensitivity C-reactive protein (ng/ml)

6.8 ± 0.56

6.4 ± 0.7

0.0016

Interleukin-6 (pg/ml)

202.4 ± 27.5

189 ± 30.8

0.0216

Tumor necrosis factor-α (pg/ml)

2.01 ± 0.74

1.56 ± 0.52

0.0002

Visfatin (ng/ml)

7.54 ± 1.1

6.93 ± 0.78

0.0003

Adiponectin (µg/ml)

10 ± 3.79

8.15 ± 2.48

0.0019

  1. Data are presented as mean; standard deviation; RAF: Recurrent atrial fibrillation; p < 0.05 indicates a significant difference; p > 0.05 indicates a non-significant difference